Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Labcorp HoldingsLTS:0JSY +1.27%77 3-Year Book Growth Rate is -2.90% as of Jun. 2026. GuruFocus rates LTS:0JSY with a GF Score™ of 77/100 and a GF Value™ of $277.46 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, Labcorp Holdings ranks worse than 51.55% on this metric.
During the past 12 months, Labcorp Holdings's average Book Value per Share Growth Rate was 4.10% per year.
During the past 3 years, the average Book Value per Share Growth Rate was -2.90% per year.
During the past 5 years, the average Book Value per Share Growth Rate was -0.60% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 8.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Labcorp Holdings was 47.40% per year. The lowest was -28.30% per year. And the median was 11.45% per year.
Labcorp Holdings (LTS:0JSY) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Labcorp Holdings 3-Year Book Growth Rate Related Terms
LTS:0JSY vs DGX, MTD, GH: 3-Year Book Growth Rate Comparison
For the Diagnostics & Research subindustry, Labcorp Holdings's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labcorp Holdings 3-Year Book Growth Rate vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Labcorp Holdings's 3-Year Book Growth Rate falls into.
Labcorp Holdings 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of -2.90% mean?
Labcorp Holdings (LTS:0JSY) has a 3-Year Book Growth Rate of -2.90% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Labcorp Holdings and its competitors. According to the industry distribution chart, Labcorp Holdings ranks #100 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 51.5%.
Is Labcorp Holdings' 3-Year Book Growth Rate too high?
Labcorp Holdings' current 3-Year Book Growth Rate is -2.90%. Based on the distribution chart, Labcorp Holdings ranks #100 out of 194 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Labcorp Holdings has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' 3-Year Book Growth Rate compare to DGX and MTD?
According to the Medical Diagnostics & Research industry distribution chart, Labcorp Holdings ranks #100 out of 194 companies for 3-Year Book Growth Rate. This places Labcorp Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Medical Diagnostics & Research company?
A good 3-Year Book Growth Rate depends on the Medical Diagnostics & Research industry context. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Labcorp Holdings and its competitors. Labcorp Holdings's current 3-Year Book Growth Rate is -2.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (LTS:0JSY) is currently considered Modestly Overvalued. The stock's GF Value™ is $277.46, compared to a current price of $335.21 — trading 20.8% above its estimated fair value. The current 3-Year Book Growth Rate is -2.90%. Labcorp Holdings' overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Labcorp Holdings (LTS:0JSY), the current 3-Year Book Growth Rate is -2.90% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Labcorp Holdings (LTS:0JSY) Overvalued in 2026?
Based on GuruFocus' analysis, Labcorp Holdings stock appears to be overvalued.
The current stock price of $335.21 is trading 20.8% above its estimated GF Value™ of $277.46.
GuruFocus considers Labcorp Holdings to be Modestly Overvalued.
Key valuation signals for LTS:0JSY:
3-Year Book Growth Rate: -2.90%
GF Value™: $277.46 vs. price of $335.21 (20.8% above fair value)
No single metric tells the full story. See the LTS:0JSY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
77GF Score
Get the complete analysis for LTS:0JSY
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0JSY has been successfully added to your 
